Menu
Not yet recruiting NCT07114042

HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding

Observational Upper Gastrointestinal Bleeding

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Upper endoscopy.
Who it may be relevant to
Registry conditions: Upper Gastrointestinal Bleeding. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Moglobin, Albumin, Lymphocyte and Platelet Score as a Novel Predictor of Mortality and Re-bleeding in Patients With Upper Gastrointestinal Bleeding

Overview

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Detailed description

Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re\_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Interventions

  • Diagnostic test Upper endoscopy
    Prediction of upper gastrointestinal r\_bleeding and mortality

Primary outcome measures

  • "Mortality" [Time frame: 6 months]
  • Incidence of "Re_bleeding" [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Exclusion criteria

  • Incomplete clinical data.
  • Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
  • Pregnancy
  • Patients with missing data on clinical outcomes

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • Faculty of Medicine -Sohag university — Sohag

Identifiers

NCT: NCT07114042 · Soh-med--25-7-11MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗